Iodide

Iodide

SCHEMBL317583

CCn1cc[n+](CC)c1C.[I-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
CA1 P00915 10/20 0.42
CA2 P00918 10/20 0.42
EEF2K O00418 2/20 0.41
EEF2 P13639 2/20 0.41
MEN1 O00255 1/20 0.39
PLK4 O00444 1/20 0.39
JAK2 O60674 1/20 0.39
EGFR P00533 1/20 0.39
TYK2 P29597 1/20 0.39
FLT3 P36888 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
ITK Q08881 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
LMNA P02545 1/20 0.30
HPGD P15428 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL487079 0.98 MAPT (0.47) MAPTCTDSP1CA1CA2EEF2K
Dimethylamine SCHEMBL15348236 0.91 MAPT (0.44) MAPTCTDSP1CA1CA2EEF2K
SCHEMBL487095 0.83 CA1 (0.51) MAPTCTDSP1CA1CA2EEF2K
SCHEMBL487096 0.82 CA1 (0.50) MAPTCTDSP1CA1CA2EEF2K
SCHEMBL3312957 0.79 CA1 (0.57) MAPTCTDSP1CA1CA2EEF2K
SCHEMBL3458267 0.79 CA1 (0.38) MAPTCTDSP1CA1CA2EEF2K
SCHEMBL3312955 0.78 CA1 (0.60) MAPTCTDSP1CA1CA2EEF2K
SCHEMBL3313833 0.78 KMT2A (0.63) MAPTCTDSP1CA1CA2EEF2K
SCHEMBL3457800 0.78 ACHE (0.41) MAPTCTDSP1CA1CA2EEF2K
Hydrochloric Acid SCHEMBL30980166 0.78 CA1 (0.55) MAPTCTDSP1CA1CA2EEF2K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006469-B2 Luminescence quenching compounds ANASPEC INCORPORATED (US) 2015-04-14 US disclosed
US-20140031524-A1 Luminescence quenching compounds ANASPEC INCORPORATED (US) 2014-01-30 US disclosed
US-8426618-B2 Luminescence quenching compounds ANASPEC INCORPORATED (US) 2013-04-23 US disclosed
US-20120123109-A1 Luminescence quenching compounds ANASPEC INCORPORATED (US) 2012-05-17 US disclosed
US-8093411-B2 Cyanine dyes and their applications as luminescence quenching compounds ANASPEC INCORPORATED (US) 2012-01-10 US disclosed
US-7910753-B2 Cyanine dyes and their applications as luminescence quenching compounds ANASPEC INCORPORATED (US) 2011-03-22 US disclosed
US-20100331543-A1 Cyanine dyes and their applications as luminescence quenching compounds DIWU ZHENJUN 2010-12-30 US disclosed
US-20060223076-A1 Cyanine dyes and their applications as luminescence quenching compounds ANASPEC, INC. (US) 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223076-A1 Cyanine dyes and their applications as luminescence quenching compounds TYR, ABCG2, CYBA MAPT 1317/4885CTDSP1 4724/4885CA1 2730/4885
US-20100331543-A1 Cyanine dyes and their applications as luminescence quenching compounds TYR, ABCG2, CYBA MAPT 1317/4885CTDSP1 4724/4885CA1 2730/4885
US-20120123109-A1 Luminescence quenching compounds ABCG2, TYR, GFPT1 MAPT 1380/4885CTDSP1 4705/4885CA1 3176/4885
US-20140031524-A1 Luminescence quenching compounds ABCG2, TYR, GFPT1 MAPT 1380/4885CTDSP1 4705/4885CA1 3176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.